What’s New


Jun 3, 2024

Scoring Indices for Perianal Fistulising Crohn’s Disease: A Systematic Review

Christopher Ma, Vipul Jairath.


May 30, 2024

Alimentiv DDW 2024 Presentations

If you’ve missed some of our lecture presentations and poster sessions, reach out for more information….


Mar 1, 2024

Recommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn’s Disease Clinical Trials

Brian Feagan, Eileen Crowley, Guangyong Zou, Jordi Rimola, Julie Rémillard, Vipul Jairath.


Feb 28, 2024

Identification of immune cell markers associated with ulcerative colitis histological disease activity in colonic biopsies

Brian Feagan, Guangyong Zou, Niels Vande Casteele, Vipul Jairath.


Feb 8, 2024

Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trial

Brian Feagan, Gabriela Radulescu, Geert D’Haens, Rocio Sedano, Vipul Jairath.


Jan 8, 2024

Alimentiv Announces Pierre Gaudreault as New Chief Executive Officer

London, Ontario, Canada, January 8, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce the appointment of Pierre Gaudreault as its Chief Executive Officer, effective January 2024. Th…


Dec 9, 2023

Use of external control arms in immune-mediated inflammatory diseases: a systematic review

Brian Feagan, Christopher Ma, Vipul Jairath.


Dec 3, 2023

Reliability and Responsiveness of Histologic Indices for the Assessment of Crohn’s Disease Activity

Brian Feagan, Claire E Parker, Geert D’Haens, Guangyong Zou, Julie Rémillard, Niels Vande Casteele, Vipul Jairath.